Jupiter Neurosciences, Inc. (JUNS)

Jupiter Neurosciences will go public soon, but the exact IPO date is still unknown.
Stock Price: $5.00 - $7.00
Current IPO price range
Chart not available yet
Data will show when the stock starts trading.
Market Cap98.46M
Revenue (ttm)1.76M
Net Income (ttm)-2.06M
Shares Out16.41M
EPS (ttm)-0.13
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About JUNS

Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL™, has many potential indications of use for rare diseases, which of we primarily are targeting Mucopolysaccharidoses Type 1, Friedreich’s Ataxia, and MELAS as well as ALS which is in an early development stage. In the larger disease areas, we are primarily targeting Mild Cognitive Impairment/early Alzheimer’s disease ...

IndustryPharmaceuticals
Founded2015
CEOChrister Rosén
Employees5
Stock ExchangeNASDAQ
Ticker SymbolJUNS
Full Company Profile

Financial Performance

Financial Statements

News

Jupiter Neurosciences IPO Registration Document (S-1)

Jupiter Neurosciences, Inc. has filed to go public with an IPO on the NASDAQ.

3 months ago - SEC